IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 24 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 398,145 | $2,397,000 | 0.24% |
| INGALLS & SNYDER LLC | 600,810 | $3,617,000 | 0.16% |
| Ikarian Capital, LLC | 150,000 | $903,000 | 0.07% |
| Gradient Capital Advisors, LLC | 21,718 | $131,000 | 0.06% |
| WEST PACES ADVISORS INC. | 1,665 | $10,023 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,115 | $103,000 | 0.00% |
| Orion Portfolio Solutions, LLC | 14,111 | $85,000 | 0.00% |
| MARSHALL WACE, LLP | 36,259 | $218,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 12,538 | $75,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 88 | $1,000 | 0.00% |